Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epigenetic and genetic alterations of p33ING1b in ovarian cancer.

Carcinogenesis - 1 Apr 2005

Shen Dan-Hua, Chan Kelvin Yuen-Kwong, Khoo Ui-Soon, Ngan Hextan Yuen-Sheung, Xue Wei-Cheng, Chiu Pui-Man, Ip Philip, Cheung Annie Nga-Yin

Abstract excerpt

p33ING1b is a candidate tumor suppressor gene and a nuclear protein. We investigated whether genetic and epigenetic mechanisms affect p33ING1b expression in ovarian cancer thus contributing toward its pathogenesis. A total of 111 ovarian cancers collected from Beijing and Hong Kong were used for this study. Weak or negative p33ING1b protein expression was demonstrated by immunohistochemistry on tissue microarray...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Antimetabolites, Antineoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Azacitidine

Share to Carcinoma, Endometrioid

Share to Cystadenocarcinoma, Serous

Share to Decitabine

Share to Immunoenzyme Techniques

Source

Identifiers

PMID: 15677627
DOI: 10.1093/carcin/bgi011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Epigenetic and genetic alterations of p33ING1b in ovarian cancer.PMID 15677627Read ↗

Downregulation of nuclear expression of the p33 <sup>ING1b</sup> inhibitor of growth protein in invasive carcinoma of the breastSemantic proximity Read ↗

Prognostic value of BRCA1 promoter methylation for patients with epithelial ovarian cancer.Semantic proximity Read ↗

The role of the tumour suppressor p33 ING1b in human neoplasia.Semantic proximity Read ↗

[Significance of p33(ING1b) and p53 gene expression in hepatocellular carcinoma].Semantic proximity Read ↗

Polymorphisms in the kinesin-like factor 1 B gene and risk of epithelial ovarian cancer in Eastern Chinese women.Semantic proximity Read ↗

Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas.Semantic proximity Read ↗

Methylation Status and Expression of BRCA2 in Epithelial Ovarian Cancers in Indonesia.Semantic proximity Read ↗

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.Semantic proximity Read ↗

Aberrations of TACC1 and TACC3 are associated with ovarian cancerSemantic proximity Read ↗

Promoter methylation of IGFBP-3 and p53 expression in ovarian endometrioid carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.